Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2015 Dec 24

PMID 26694863

Citations 6

Authors

Florian Huemer

Thomas Melchardt

Wolfgang Trankenschuh

Daniel Neureiter

Gerhard Moser

Teresa Magnes

Lukas Weiss

Alexander Schlattau

Clemens Hufnagl

Gerda Ricken

Romana Hoftberger

Richard Greil

Alexander Egle

Affiliations

Soon will be listed here.

Abstract

Background: Paraneoplastic syndromes are most frequently associated with small cell lung carcinoma, hematologic and gynecologic malignancies while reports in head and neck cancer are rare.

Case Presentation: We present the case of a 60-year old female patient who developed paraneoplastic cerebellar degeneration upon locoregional recurrence of a poorly differentiated spindle cell carcinoma of the nasal cavity and paranasal sinus. The neurological symptoms, especially ataxia, stabilized after resection of tumor recurrence and concomitant chemoradiotherapy whereas anti-Hu-antibodies remained positive. Despite the unfavorable prognosis of paraneoplastic neurological disorders associated with onconeural antibodies, the patient achieved long-standing stabilization of neurological symptoms.

Conclusion: We report the first patient with anti-Hu antibodies and paraneoplastic cerebellar degeneration associated with a spindle cell carcinoma of the head and neck. We recommend that evaluation of neurological symptoms in patients with this tumor entity should also include paraneoplastic syndromes as differential diagnoses and suggest early extensive screening for onconeural antibodies.

Citing Articles

A review of the neurological complications of breast cancer.

Hekmatnia Y, Movahednia N, Hajhamidiasl N, Hekmat E, Hekmat A, Khademi S J Family Med Prim Care. 2022; 11(8):4205-4214.

PMID: 36352946 PMC: 9638659. DOI: 10.4103/jfmpc.jfmpc_580_21.

Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature.

Juarez-Vignon Whaley J, Carrera-Muinos A, Hernandez-Gutierrez K, Rodriguez-Cid J, Otero-Cerdeira M, Garcia-Montes V Case Rep Oncol. 2022; 14(3):1799-1805.

PMID: 35111012 PMC: 8787574. DOI: 10.1159/000519969.

Anti-SOX1 Antibodies in Paraneoplastic Neurological Syndrome.

Sun X, Tan J, Sun H, Liu Y, Guan W, Jia J J Clin Neurol. 2020; 16(4):530-546.

PMID: 33029958 PMC: 7541980. DOI: 10.3988/jcn.2020.16.4.530.

Various clinical features of patients with anti-Hu associated paraneoplastic neurological syndromes: An observational study.

Li J, Lin W Medicine (Baltimore). 2018; 97(18):e0649.

PMID: 29718880 PMC: 6392975. DOI: 10.1097/MD.0000000000010649.

Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies.

Fang Z, Yang Y, Chen X, Zhang W, Xie Y, Chen Y Front Immunol. 2017; 8:395.

PMID: 28487693 PMC: 5403900. DOI: 10.3389/fimmu.2017.00395.

References

Moll J, Henzen-Logmans S, Splinter T, van der Burg M, Vecht C . Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous system. J Neurol Neurosurg Psychiatry. 1990; 53(11):940-3. PMC: 488272. DOI: 10.1136/jnnp.53.11.940. View

Elrington G, Murray N, Spiro S, Newsom-Davis J . Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry. 1991; 54(9):764-7. PMC: 1014512. DOI: 10.1136/jnnp.54.9.764. View

Zarbo R, Crissman J, Venkat H, Weiss M . Spindle-cell carcinoma of the upper aerodigestive tract mucosa. An immunohistologic and ultrastructural study of 18 biphasic tumors and comparison with seven monophasic spindle-cell tumors. Am J Surg Pathol. 1986; 10(11):741-53. DOI: 10.1097/00000478-198611000-00001. View

Graus F, Delattre J, Antoine J, Dalmau J, Giometto B, Grisold W . Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004; 75(8):1135-40. PMC: 1739186. DOI: 10.1136/jnnp.2003.034447. View

Shamsili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B . Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003; 126(Pt 6):1409-18. DOI: 10.1093/brain/awg133. View

Camdessanche J, Antoine J, Honnorat J, Vial C, Petiot P, Convers P . Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain. 2002; 125(Pt 1):166-75. DOI: 10.1093/brain/awf006. View

Saloustros E, Zaganas I, Mavridis M, Vamvakas L, Plaitakis A, Georgoulias V . Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma. J Neurooncol. 2009; 97(2):291-4. DOI: 10.1007/s11060-009-0022-2. View

Keime-Guibert F, Graus F, Fleury A, Rene R, Honnorat J, Broet P . Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry. 2000; 68(4):479-82. PMC: 1736897. DOI: 10.1136/jnnp.68.4.479. View

Rojas I, Graus F, Keime-Guibert F, Rene R, Delattre J, Ramon J . Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology. 2000; 55(5):713-5. DOI: 10.1212/wnl.55.5.713. View

10.

Baijens L, Manni J . Paraneoplastic syndromes in patients with primary malignancies of the head and neck. Four cases and a review of the literature. Eur Arch Otorhinolaryngol. 2005; 263(1):32-6. DOI: 10.1007/s00405-005-0942-1. View

11.

Garcia F, Blazquez J, Martinez S . [Paraneoplastic ataxia due to laryngeal carcinoma]. Acta Otorrinolaringol Esp. 1998; 49(5):414-5. View

12.

David Y, Warner E, Levitan M, Sutton D, Malkin M, Dalmau J . Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report. Cancer. 1996; 78(10):2153-6. View

13.

Uchuya M, Graus F, Vega F, Rene R, Delattre J . Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry. 1996; 60(4):388-92. PMC: 1073889. DOI: 10.1136/jnnp.60.4.388. View

14.

Minotti A, Kountakis S, Stiernberg C . Paraneoplastic syndromes in patients with head and neck cancer. Am J Otolaryngol. 1994; 15(5):336-43. DOI: 10.1016/0196-0709(94)90132-5. View

15.

Posner J, Furneaux H . Paraneoplastic syndromes. Res Publ Assoc Res Nerv Ment Dis. 1990; 68:187-219. View